Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.
Sign Up to like & getrecommendations! Published in 2017 at "Annals of diagnostic pathology"
DOI: 10.1016/j.anndiagpath.2016.10.010
Abstract: Malignant mesothelioma is a highly aggressive neoplasm, and the histologic subtype is one of the most reliable prognostic factors. Some biphasic mesotheliomas are difficult to distinguish from epithelioid mesotheliomas with atypical fibrous stroma. The aim… read more here.
Keywords: mesothelioma; mesotheliomas; biphasic mesothelioma; p16 cdkn2a ... See more keywords
Metastasis of Sarcomatoid Malignant Mesothelioma With p16/CDKN2A Deletion Manifested as a Subcutaneous Mass in the Back: A Case Report and Review of Literature.
Sign Up to like & getrecommendations! Published in 2021 at "International journal of surgical pathology"
DOI: 10.1177/10668969211005094
Abstract: Sarcomatoid malignant mesothelioma (MM) is a rare and aggressive disease, and its diagnosis is challenging. A 60-year-old man presented with a recurrent subcutaneous mass in his right back after the initial resection. A chest computed… read more here.
Keywords: subcutaneous mass; p16; mass; sarcomatoid malignant ... See more keywords